Stay updated on Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial
Sign up to get notified when there's something new on the Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial page.

Latest updates to the Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe NIH banner announcing a terminology transition and linking to related updates and FAQs was removed; the page still shows a 403 error.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide notice says NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check61 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error instead of showing the study details. This indicates an access restriction or site issue preventing retrieval of the NCT03978208 record.SummaryDifference18%

Stay in the know with updates to Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial page.